Instructions for Actitropil (Phenotropil) [Phenylpiracetam] 30 pills 100 mg
tab 50 mg: 30 pcs
tab. 100 mg: 30 pcs
Tablets from white to white with a yellowish or brownish color, squamous cylindrical, with a bevy, allowed marbling.
Phenylpiracetam 50 mg
Auxiliary substances: cellulose microcrystalline 101 - 9 mg, povidone K17 - 20 mg, hyprolose - 10 mg, sodium hydrogen carbonate - 10 mg, stearic acid - 1 mg.
10 pcs - box-type contour (3) packages - cardboard packs.
15 pcs - packages of box contour (2) - cardboard packs.
30 pcs - cans - cardboard packs.
N06BX Other psychostimulants and nootropic drugs Phenylpiracetam
Clinical-pharmacological groups / Group affiliation
Diseases of CNS of different genesis
especially diseases of vascular genesis or associated with disorders of metabolic processes in the brain and intoxication (in particular, in posttraumatic conditions and phenomena of chronic cerebrovascular insufficiency)
accompanied by deterioration of intellectual and mnestic functions
reduction of motor activity;
Neurotic conditions, such as sluggishness,
decreased psychomotor activity,
Disruption of learning processes mild to moderate depression;
Psychoorganic syndromes that show intellectual-mnestic disorders and apatico-abulic symptoms, as well as listopathic conditions in schizophrenia;
obesity (alimentary-constitutional genesis);
Prevention of hypoxia,
increasing resistance to stress;
correction of the functional state of the body in extreme conditions of professional activity in order to prevent the development of fatigue and increase mental and physical efficiency; correction of daily biorhythm, regulation of the sleep-wake cycle;
chronic alcoholism (in order to reduce symptoms of asthma,
Method of use, course and dosage:
Inside. Individual dosing regime, depending on the indications, patient's age and clinical situation.
Drug Phenylpiracetam interaction
It may enhance the effects of CNS-stimulating drugs Phenylpiracetam, antidepressants and nootropic drugs.
Application for kidney disorders
With caution, patients with severe organic kidney lesions.
Use in liver disorders
With caution, patients with severe organic liver lesions.
Application in elderly patients
Use with caution in elderly patients to avoid exacerbating the course of underlying health conditions.
Use in children
The preparation is contraindicated for use in children and adolescents under the age of 18
Nosology Phenylpiracetam (ICD codes)
Personality and behavioural disorders caused by disease, damage or brain dysfunction
Bipolar affective disorder
Recurrent depressive disorder
Mixed anxiety and depressive disorder
Response to severe stress and adaptation disorders
Neurotic disorder unspecified
Sleep and wake disorders of inorganic etiology
Specific learning disabilities
Sleep and wakefulness disorders
Effects of cerebrovascular disease
Cramp and spasm
Demoralization and Apathy
Effects of head injuries
Stress conditions not classified in other headings (physical and mental stress)
Pharmacological effect Phenylpiracetam:
The nootropic preparation Phenylpiracetam has a pronounced antiamnestic effect.
It has a direct activating effect on the integrative activity of the brain, promotes memory consolidation
improves concentration and mental activity
increases the speed of information transfer between brain hemispheres
It increases the resistance of brain tissue to hypoxia and toxic effects on the brain.
Also has anticonvulsive effect and anxiolytic activity regulate the processes of activation and inhibition of the central nervous system. improve mood.
It has a positive effect on metabolic processes and brain circulation.
stimulates oxidation-reduction processes
It improves the body's energy potential through glucose utilization and improves regional blood flow in ischemic areas of the brain.
Best price everywhere